The Next Small Step Towards Safer Immuno-oncology Drugs
Working Together in the Fight Against Cancer
This new paper related to cancer therapies is from our friends at BioCopy GmbH. It's about their high-throughput method for the kinetic evaluation of pHLA binding therapeutic molecules and the development and characterisation of therapeutic molecules.
We all wish for as much progress as possible to be made in the fight against cancer, and we congratulate and support every effort to achieve this. So take a few moments to read, learn and be inspired by a company striving to do just that.
The peptide HLA microarrays in this study were printed on an iTWO instrument from M2-Automation GmbH. We are so glad that our biotech is being put to such valuable use.
-- This paper has been submitted to Nature Scientific Reports. Click here to read the paper.
-- The authors are: Stefan Krämer, Andreas Moritz, Luca Stehl, Meike Hutt, Martin Hofmann, Claudia Wagner, Sebastian Bunk, Dominik Maurer, Dr. Günther Roth and Johannes Wöhrle.
More on BioCopy’s label-free kinetics technology: Click here
Check out our iTWO playlist on our YouTube channel - the M2TechChannel: iTWO playlist
-- Please remember to Like and Subscribe! And thank you for helping us to grow our channel. We really appreciate your support.
For all the detailed info and tech specs of our iTWO, click here.